Insider filing · RAPP
Krishnaswamy Yeleswaram
Chief Development Officer
profile →
Rapport Therapeutics, Inc.
RAPP · Healthcare · 38 filings in 24 months
ticker →
Krishnaswamy Yeleswaram sold $678K of Rapport Therapeutics (RAPP)
Executed Apr 13, disclosed Apr 14, 1 day later.
Value, as filed
$678K
19,365 sh across 2 lots
Executed
Apr 13
the trade date, as filed
Disclosed
Apr 14
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
KYKrishnaswamy Yeleswaram (Chief Development Officer) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Rapport Therapeutics, Inc. (RAPP). The largest single filing was $2.5M of RAPP (50,160 sh across 3 lots, as filed), executed Aug 24.
The name
RAPPHealthcare · Rapport Therapeutics, Inc., operates as a clinical-stage biopharmaceutical company that focuses on the discovery and development of transfo…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Krishnaswamy Yeleswaram in RAPP
RAPPSALE
Rapport Therapeutics, Inc.
$2.5M50,160 sh across 3 lots
Exec Aug 24
Filed Aug 26 · 4:00 PM ET RAPPSALE Rapport Therapeutics, Inc. $809K
20,225 sh × $39.99
Exec Apr 17
Filed Apr 21 · 5:30 PM ET RAPPSALE Rapport Therapeutics, Inc. $303K
10,115 sh × $29.99
Exec Mar 25
Filed Mar 26 · 5:30 PM ET